SV Life Sciences Adds Health Care Services Veteran Paul Wallace as Venture Partner

BOSTON--(Business Wire)--
SV Life Sciences ("SVLS") today announced the appointment of Paul Wallace, an
executive with over 18 years of experience in health care services operations
and private equity investing, as a Venture Partner. Mr. Wallace will be working
on the SVLS health care services team.

Mr. Wallace was most recently Senior Vice President of Healthways, Inc., a
publicly held, Nashville-based provider of disease management, wellness and
population health support solutions. His roles at Healthways included oversight
of strategic planning, corporate development and sales & marketing. His
leadership on acquisitions, joint ventures and strategic sales initiatives was
instrumental in driving revenue from $120 million to $730 million. Prior to
Healthways, Mr. Wallace was a senior investment officer at Petra Capital in
Nashville, Gilbert Global Equity Partners (fka Soros Capital) in New York,
Lazard Asia Investment Management in Singapore, and GTCR in Chicago. His
principal investment experience includes more than 50 completed transactions
representing over $1.3 billion of equity capital. He holds an MBA from the
Kellogg School of Management at Northwestern University and a BA from the
University of Richmond.

"We are very pleased to have Paul Wallace, a seasoned veteran of both the health
care services and financial sectors, join the SVLS team as a Venture Partner,"
said Darren Black, SVLS Partner. "Paul`s operations experience in growing a
leading public health care service provider, coupled with his many years as a
successful investment professional, will be a great asset to the SVLS health
care services team."

About SV Life Sciences

SV Life Sciences is a leading international life sciences venture capital firm.
SVLS affiliated funds have been investing in life sciences companies since the
early 1980s and the firm closed its first dedicated life sciences fund in 1994.
The SVLS team manages five venture capital funds and a publicly traded
investment trust with approximately $2 billion of capital under management. The
firm employs a diversified strategy within life sciences in order to selectively
capitalize on an expanding opportunity in biotech, medical devices and health
care services. The SVLS health care services team is seeking to invest $5
million to $35 million in high growth, profitable health care services
businesses with proven management teams. SVLS has offices in Boston, London and
San Francisco. For more information, please visit the company`s website at
http://www.svlsa.com.

SV Life Sciences
Denise Marks, Partner, +1-617-367-8100
Denise.Marks@SVLSA.com
or
Kureczka/Martin Associates
Joan Kureczka, +1-415-821-2413
Joan@Kureczka-Martin.com

Copyright Business Wire 2010